Vault-13

Endurant Capital Management LP

San Mateo, CA · CIK 1633055 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$262.2m reported value -20.9% vs Q1 2022
47positions
60.5%in top 10
18 new 11 added 15 reduced 31 sold out vs Q1 2022

Options: 1 call positions ($9.4m notional), 2 put positions ($13.5m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INVACARE CORP NOTE 5.000%11/1 IVC 5 11.15.24 IVC 5 11.15.24 56,727,000 $50.0m19.07% 19.07% UnchangedShares held: Q3 2021 0, Q4 2021 56.7m, Q1 2022 56.7m, Q2 2022 56.7m
2 QIAGEN NV SHS NEW SHS NEW 398,221 $18.8m7.17% 7.17% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 55.7k, Q2 2022 398.2k +342.6k +342,565 615.5%
3 BOSTON SCIENTIFIC CORP COM BSX BSX 418,165 $15.6m5.94% 5.94% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 418.2k
4 AVANTOR INC COM AVTR AVTR 450,821 $14.0m5.35% 5.35% AddedShares held: Q3 2021 162.0k, Q4 2021 107.0k, Q1 2022 285.9k, Q2 2022 450.8k +164.9k +164,920 57.7%
5 HUMANA INC COM HUM HUM 27,106 $12.7m4.84% 4.84% ReducedShares held: Q3 2021 44.0k, Q4 2021 34.0k, Q1 2022 29.1k, Q2 2022 27.1k -2.0k -2,014 -6.9%
6 ICON PLC SHS ICLR ICLR 49,718 $10.8m4.11% 4.11% NewShares held: Q3 2021 46.7k, Q4 2021 0, Q1 2022 0, Q2 2022 49.7k
7 THE CIGNA GROUP COM CI CI 40,372 $10.6m4.06% 4.06% AddedShares held: Q3 2021 36.2k, Q4 2021 36.6k, Q1 2022 28.7k, Q2 2022 40.4k +11.7k +11,655 40.6%
8 INVACARE CORP NOTE 5.000%11/1 IVC 5 11.15.24 * IVC 5 11.15.24 * 10,097,000 $9.2m3.53% 3.53% UnchangedShares held: Q3 2021 0, Q4 2021 10.1m, Q1 2022 10.1m, Q2 2022 10.1m
9 HOLOGIC INC COM HOLX HOLX 127,656 $8.8m3.37% 3.37% AddedShares held: Q3 2021 200.1k, Q4 2021 181.1k, Q1 2022 123.6k, Q2 2022 127.7k +4.0k +4,032 3.3%
10 LABORATORY CORP AMER HLDGS COM NEW COM NEW 34,718 $8.1m3.10% 3.10% ReducedShares held: Q3 2021 18.8k, Q4 2021 65.4k, Q1 2022 61.3k, Q2 2022 34.7k -26.6k -26,561 -43.3%
11 ELUTIA INC CL A COM ELUT ELUT 1,133,183 $8.0m3.06% 3.06% AddedShares held: Q3 2021 952.6k, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m +23.7k +23,704 2.1%
12 BIO RAD LABS INC CL A BIO BIO 16,028 $7.9m3.03% 3.03% ReducedShares held: Q3 2021 18.3k, Q4 2021 14.5k, Q1 2022 17.2k, Q2 2022 16.0k -1.1k -1,123 -6.5%
13 ZOETIS INC CL A ZTS ZTS 41,100 $7.1m2.69% 2.69% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 41.1k
14 SELECTA BIOSCIENCES INC COM COM 4,611,635 $6.0m2.30% 2.30% AddedShares held: Q3 2021 1.0m, Q4 2021 2.1m, Q1 2022 3.5m, Q2 2022 4.6m +1.2m +1,159,677 33.6%
15 SEAGEN INC COM SGEN SGEN 32,871 $5.8m2.22% 2.22% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 32.9k
16 CENTENE CORP DEL COM CNC CNC 68,305 $5.8m2.20% 2.20% ReducedShares held: Q3 2021 0, Q4 2021 70.8k, Q1 2022 218.2k, Q2 2022 68.3k -149.9k -149,930 -68.7%
17 BAXTER INTL INC COM BAX BAX 89,863 $5.8m2.20% 2.20% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 89.9k
18 SI-BONE INC COM SIBN SIBN 430,159 $5.7m2.17% 2.17% AddedShares held: Q3 2021 471.2k, Q4 2021 767.1k, Q1 2022 413.4k, Q2 2022 430.2k +16.8k +16,789 4.1%
19 MCKESSON CORP COM MCK MCK 15,984 $5.2m1.99% 1.99% ReducedShares held: Q3 2021 32.6k, Q4 2021 0, Q1 2022 29.2k, Q2 2022 16.0k -13.2k -13,184 -45.2%
20 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 459,829 $3.5m1.32% 1.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 459.8k
21 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 1,824,065 $3.1m1.18% 1.18% ReducedShares held: Q3 2021 917.5k, Q4 2021 897.6k, Q1 2022 2.2m, Q2 2022 1.8m -336.8k -336,825 -15.6%
22 OCULAR THERAPEUTIX INC COM OCUL OCUL 760,228 $3.1m1.17% 1.17% ReducedShares held: Q3 2021 610.4k, Q4 2021 717.1k, Q1 2022 924.0k, Q2 2022 760.2k -163.7k -163,735 -17.7%
23 GALAPAGOS NV SPON ADR LKFT LKFT 51,410 $2.9m1.09% 1.09% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 52.4k, Q2 2022 51.4k -990 -990 -1.9%
24 INSMED INC COM PAR $.01 INSM INSM 142,071 $2.8m1.07% 1.07% ReducedShares held: Q3 2021 159.9k, Q4 2021 89.2k, Q1 2022 165.3k, Q2 2022 142.1k -23.2k -23,209 -14.0%
25 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 27,992 $2.7m1.04% 1.04% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 28.0k
26 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 81,007 $2.6m0.99% 0.99% AddedShares held: Q3 2021 0, Q4 2021 42.8k, Q1 2022 43.2k, Q2 2022 81.0k +37.8k +37,757 87.3%
27 TENET HEALTHCARE CORP COM NEW THC THC 47,442 $2.5m0.95% 0.95% ReducedShares held: Q3 2021 179.3k, Q4 2021 146.9k, Q1 2022 131.4k, Q2 2022 47.4k -83.9k -83,934 -63.9%
28 INCYTE CORP COM INCY INCY 31,211 $2.4m0.90% 0.90% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 31.2k
29 SPDR SER TR S&P BIOTECH XBI XBI 31,349 $2.3m0.89% 0.89% ReducedShares held: Q3 2021 0, Q4 2021 48.9k, Q1 2022 46.4k, Q2 2022 31.3k -15.1k -15,091 -32.5%
30 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 25,975 $2.2m0.82% 0.82% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 26.0k
31 DEXCOM INC COM DXCM DXCM 26,046 $1.9m0.74% 0.74% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 26.0k
32 SUTRO BIOPHARMA INC COM COM 357,465 $1.9m0.71% 0.71% AddedShares held: Q3 2021 0, Q4 2021 111.8k, Q1 2022 296.5k, Q2 2022 357.5k +61.0k +60,957 20.6%
33 FATE THERAPEUTICS INC COM FATE FATE 71,640 $1.8m0.68% 0.68% AddedShares held: Q3 2021 0, Q4 2021 37.3k, Q1 2022 59.7k, Q2 2022 71.6k +11.9k +11,908 19.9%
34 ARCUS BIOSCIENCES INC COM RCUS RCUS 64,756 $1.6m0.63% 0.63% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 38.6k, Q2 2022 64.8k +26.1k +26,106 67.5%
35 CENCORA INC COM COR COR 11,515 $1.6m0.62% 0.62% NewShares held: Q3 2021 21.4k, Q4 2021 115.0k, Q1 2022 0, Q2 2022 11.5k
36 MERIT MED SYS INC COM MMSI MMSI 20,223 $1.1m0.42% 0.42% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 20.2k
37 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 16,189 $1.1m0.42% 0.42% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 16.2k
38 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 9,949 $1.0m0.40% 0.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 9.9k
39 ALBIREO PHARMA INC COM BIOD BIOD 37,835 $751.0k0.29% 0.29% ReducedShares held: Q3 2021 117.3k, Q4 2021 65.6k, Q1 2022 120.8k, Q2 2022 37.8k -83.0k -82,999 -68.7%
40 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 8,454 $674.0k0.26% 0.26% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 8.5k
41 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 23,015 $654.0k0.25% 0.25% NewShares held: Q3 2021 29.8k, Q4 2021 0, Q1 2022 0, Q2 2022 23.0k
42 AXSOME THERAPEUTICS INC COM AXSM AXSM 15,246 $584.0k0.22% 0.22% ReducedShares held: Q3 2021 52.0k, Q4 2021 55.6k, Q1 2022 100.3k, Q2 2022 15.2k -85.1k -85,053 -84.8%
43 ADC THERAPEUTICS SA SHS ADCT ADCT 58,967 $469.0k0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 59.0k
44 CYTOKINETICS INC COM NEW CYTK CYTK 11,538 $453.0k0.17% 0.17% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 11.5k
45 BIODESIX INC COM COM 130,753 $214.0k0.08% 0.08% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 130.8k, Q2 2022 130.8k
46 PRAXIS PRECISION MEDICINES I COM COM 79,097 $194.0k0.07% 0.07% ReducedShares held: Q3 2021 153.6k, Q4 2021 89.6k, Q1 2022 79.5k, Q2 2022 79.1k -355 -355 -0.5%
47 IMMUNIC INC COM COM 30,591 $106.0k0.04% 0.04% ReducedShares held: Q3 2021 185.4k, Q4 2021 184.5k, Q1 2022 130.6k, Q2 2022 30.6k -100.0k -99,976 -76.6%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ASTRAZENECA PLC 240,271 $15.9m240.3k shares
ORTHOFIX MED INC OFIX OFIX 434,803 $14.2m434.8k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 194,684 $14.2m194.7k shares
SYNEOS HEALTH INC INCR INCR 123,232 $10.0m123.2k shares
EDWARDS LIFESCIENCES CORP EW EW 44,561 $5.2m44.6k shares
INTUITIVE SURGICAL INC ISRG ISRG 17,232 $5.2m17.2k shares
ENCOMPASS HEALTH CORP EHC EHC 65,653 $4.7m65.7k shares
ADAPTHEALTH CORP AHCO AHCO 248,314 $4.0m248.3k shares
IDEXX LABS INC IDXX IDXX 5,729 $3.1m5.7k shares
PREMIER INC PINC PINC 75,632 $2.7m75.6k shares
METTLER TOLEDO INTERNATIONAL MTD MTD 1,765 $2.4m1.8k shares
TANDEM DIABETES CARE INC TNDM TNDM 18,236 $2.1m18.2k shares
KARUNA THERAPEUTICS INC 15,342 $1.9m15.3k shares
10X GENOMICS INC TXG TXG 24,923 $1.9m24.9k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 15,400 $1.8m15.4k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 6,982 $1.8m7.0k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 10,379 $1.7m10.4k shares
AFFIMED N V 354,492 $1.5m354.5k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 83,217 $1.5m83.2k shares
ARGENX SE ARGX ARGX 4,480 $1.4m4.5k shares
ICU MED INC ICUI ICUI 6,093 $1.4m6.1k shares
RHYTHM PHARMACEUTICALS INC RYTM RYTM 105,792 $1.2m105.8k shares
MOLECULAR TEMPLATES INC 314,238 $1.1m314.2k shares
CAREDX INC CDNA CDNA 28,048 $1.0m28.0k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 60,720 $1.0m60.7k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 25,900 $9.8m25.9k shares Reduced
SPDR SER TR XBI · Call XBICall 126,000 $9.4m126.0k shares Unchanged
INVESCO QQQ TR QQQ · Put QQQPut 13,300 $3.7m13.3k shares New